Lavaca Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.1K | Buy |
447
+162
| +57% | +$20.3K | 0.02% | 150 |
|
|
2025
Q1 | $39K | Buy |
285
+257
| +918% | +$35.2K | 0.02% | 156 |
|
|
2024
Q4 | $4.28K | Buy |
+28
| New | +$4.28K | ﹤0.01% | 274 |
|
|
2023
Q4 | – | Sell |
-1,434
| Closed | -$369K | – | 91 |
|
|
2023
Q3 | $369K | Sell |
1,434
-17
| -1% | -$4.37K | 0.12% | 112 |
|
|
2023
Q2 | $413K | Buy |
1,451
+89
| +7% | +$25.4K | 0.12% | 110 |
|
|
2023
Q1 | $379K | Sell |
1,362
-114
| -8% | -$31.7K | 0.08% | 124 |
|
|
2022
Q4 | $409K | Sell |
1,476
-95
| -6% | -$26.3K | 0.13% | 113 |
|
|
2022
Q3 | $418K | Sell |
1,571
-5
| -0.3% | -$1.33K | 0.15% | 85 |
|
|
2022
Q2 | $322K | Buy |
1,576
+41
| +3% | +$8.38K | 0.05% | 92 |
|
|
2022
Q1 | $323K | Buy |
+1,535
| New | +$323K | 0.03% | 100 |
|
|
2019
Q2 | – | Sell |
-45
| Closed | -$11K | – | 114 |
|
|
2019
Q1 | $11K | Hold |
45
| – | – | 0.01% | 257 |
|
|
2018
Q4 | $14K | Buy |
+45
| New | +$14K | 0.01% | 202 |
|